Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules

Roberto Valcavi, Andrea Frasoldati

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To provide an overview of ultrasound (US)-guided percutaneous ethanol injection (PEI) therapy for thyroid cystic nodules and discuss the practical and technical details. Methods: We present preliminary data of a controlled randomized study involving 281 patients (221 women and 60 men; 18 to 85 years old) with benign thyroid cystic nodules. Study inclusion criteria were local discomfort or cosmetic damage, cystic volume more than 2 mL, 50% or more fluid component, benignity as confirmed by cytologic specimen obtained by US-guided fine-needle aspiration biopsy (FNAB), and euthyroidism. Exclusion criteria were inadequate, suspicious, or positive FNAB cytology, high serum calcitonin, and contralateral laryngeal cord palsy. By random assignment, 138 patients underwent simple cyst evacuation, and 143 underwent cyst evacuation plus PEI by a skilled operator using a US-guided technique. The amount of ethanol injected was 50 to 70% of the cystic fluid extracted. Results: Before treatment, the mean (±SD) nodule volume was 19.0 ± 19.0 mL versus 20.0 ± 13.4 mL in the PEI versus the simple evacuation group (no significant difference). After 1 year, volumes were 5.5 ± 11.7 mL versus 16.4 ± 13.7 mL (P

Original languageEnglish
Pages (from-to)269-275
Number of pages7
JournalEndocrine Practice
Volume10
Issue number3
Publication statusPublished - May 2004

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules'. Together they form a unique fingerprint.

Cite this